Barinthus Biotherapeutics (BRNS) Earnings Date, Estimates & Call Transcripts → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free BRNS Stock Alerts $2.34 -0.01 (-0.43%) (As of 05/10/2024 08:54 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMar. 20EstimatedActual EPS (Mar. 20) -$0.45 Beat By $0.10 Consensus EPS (Mar. 20) -$0.55 Get Barinthus Biotherapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for BRNS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBRNS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BRNS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Tomorrow InvestorThe Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest Barinthus Biotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.67)($0.59)($0.63)Q2 20242($0.66)($0.59)($0.63)Q3 20242($0.68)($0.58)($0.63)Q4 20241($0.58)($0.58)($0.58)FY 20247($2.59)($2.34)($2.47)Q1 20251($0.71)($0.71)($0.71)Q2 20251($0.71)($0.71)($0.71)Q3 20251($0.73)($0.73)($0.73)Q4 20251($0.72)($0.72)($0.72)FY 20254($2.87)($2.87)($2.87)BRNS Earnings Date and InformationBarinthus Biotherapeutics last announced its earnings results on March 20th, 2024. The reported ($0.45) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.55) by $0.10. Barinthus Biotherapeutics has generated ($1.92) earnings per share over the last year (($1.92) diluted earnings per share). Earnings for Barinthus Biotherapeutics are expected to decrease in the coming year, from ($2.60) to ($2.93) per share. Read More Barinthus Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/20/2024Q4 2023($0.55)($0.45)+$0.10($0.45)--11/9/2023Q3 2023($0.62)($0.37)+$0.25($0.37)--8/10/2023Q2 2023($0.59)($0.62)($0.03)($0.62)$0.65 million$0.33 million5/12/2023Q1 2023($0.58)($0.48)+$0.10($0.48)$1.12 million$0.47 million3/24/2023Q4 2022($0.43)($0.55)($0.12)($0.55)$3.07 million$6.46 million11/10/2022Q3 2022($0.32)$0.22+$0.54$0.22$5.43 million$6.17 million Get the Latest News and Ratings for BRNS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022($0.41)$0.41+$0.82$0.41$2.95 million$17.06 million5/11/2022Q1 2022($0.32)$0.07+$0.39$0.07$3.57 million$15.02 million3/25/2022Q4 2021($0.36)($0.38)($0.02)($0.38)--11/12/2021Q3 2021($0.50)($0.13)+$0.37($0.13)$1.65 million$0.02 million8/12/2021Q2 2021($0.79)($0.64)+$0.15($0.64)$0.15 million$0.04 million6/14/2021Q1 2021($1.21)($0.96)+$0.25($0.02)$0.10 million$0.22 million Barinthus Biotherapeutics Earnings - Frequently Asked Questions When did Barinthus Biotherapeutics announce their last quarterly earnings? Barinthus Biotherapeutics (NASDAQ:BRNS) last announced its quarterly earning data on Wednesday, March 20, 2024. Learn more on BRNS's earnings history. Did Barinthus Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Barinthus Biotherapeutics (NASDAQ:BRNS) reported ($0.45) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.55) by $0.10. Learn more on analysts' earnings estimate vs. BRNS's actual earnings. How much revenue does Barinthus Biotherapeutics generate each year? Barinthus Biotherapeutics (NASDAQ:BRNS) has a recorded annual revenue of $800,000.00. How much profit does Barinthus Biotherapeutics generate each year? Barinthus Biotherapeutics (NASDAQ:BRNS) has a recorded net income of -$73.35 million. BRNS has generated -$1.92 earnings per share over the last four quarters. What is Barinthus Biotherapeutics's EPS forecast for next year? Barinthus Biotherapeutics's earnings are expected to decrease from ($2.60) per share to ($2.93) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Chimerix Earnings Corvus Pharmaceuticals Earnings Spero Therapeutics Earnings Q32 Bio Earnings Genelux Earnings Milestone Pharmaceuticals Earnings Oncolytics Biotech Earnings Vaccitech Earnings Reviva Pharmaceuticals Earnings InflaRx Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:BRNS) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlaceThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon to Transform U.S. Economy? Porter & CompanyBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Barinthus Biotherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
